Edition:
United Kingdom

Indoco Remedies Ltd (INRM.NS)

INRM.NS on National Stock Exchange of India

151.75INR
18 Jun 2019
Change (% chg)

Rs0.10 (+0.07%)
Prev Close
Rs151.65
Open
Rs152.70
Day's High
Rs156.90
Day's Low
Rs148.05
Volume
13,025
Avg. Vol
26,915
52-wk High
Rs238.90
52-wk Low
Rs147.15

Latest Key Developments (Source: Significant Developments)

India's Indoco Remedies March-Qtr Profit Falls
Wednesday, 29 May 2019 

May 29 (Reuters) - Indoco Remedies Ltd ::MARCH QUARTER PROFIT 116.3 MILLION RUPEES VERSUS 205 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.45 BILLION RUPEES VERSUS 2.59 BILLION RUPEES YEAR AGO.  Full Article

Indoco Remedies Says New Solid Dosages Facility At Baddi Gets UK-MHRA Approval
Wednesday, 8 May 2019 

May 8 (Reuters) - Indoco Remedies Ltd ::SAYS NEW SOLID DOSAGES FACILITY AT BADDI RECEIVES UK-MHRA APPROVAL.  Full Article

Indoco Remedies Says USFDA retains OAI status of Co's Goa Plant 1
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Indoco Remedies Ltd ::UNITED STATES FOOD AND DRUG ADMINISTRATION (USFDA) RETAINS THE OFFICIAL ACTION INDICATED (OAI) STATUS FOR GOA PLANT- I.FACILITY WAS INSPECTED BY THE USFDA IN JANUARY 2019.OAI STATUS WILL NOT IMPACT CO'S CURRENT COMMERCIAL SUPPLIES TO USA OR REVENUES FROM THE MANUFACTURING FACILITY.OAI STATUS MAY WITHHOLD APPROVAL OF CO'S PENDING ANDAS FROM FACILITY.  Full Article

Indoco Remedies Says FDA Re-Inspection Of Goa Plant-I Commences
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Indoco Remedies Ltd ::SAYS FDA RE-INSPECTION OF GOA PLANT-II COMPLETED AND PLANT-I COMMENCED.  Full Article

India's Indoco Remedies March-Qtr Profit Rises
Wednesday, 30 May 2018 

May 30 (Reuters) - Indoco Remedies Ltd ::MARCH QUARTER PROFIT 205 MILLION RUPEES VERSUS PROFIT 179.4 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.59 BILLION RUPEES VERSUS 2.66 BILLION RUPEES YEAR AGO.RECOMMENDED FINAL DIVIDEND OF 1 RUPEE PER SHARE.  Full Article

Indoco Remedies Says API Plant At Patalganga Cleared FDA Inspection With 3 Observations
Friday, 18 May 2018 

May 18 (Reuters) - Indoco Remedies Ltd ::SUCCESSFUL COMPLETION OF USFDA INSPECTION AT API MANUFACTURING FACILITIES AT PATALGANGA AND RABALE, NAVI MUMBAI..SAYS KILO LAB FACILITY RECEIVED ZERO FORM 483 FROM AGENCY.SAYS API PLANT AT PATALGANGA CLEARED INSPECTION WITH 3 OBSERVATIONS.SAYS NONE OF OBSERVATIONS AT PATALGANGA ARE CRITICAL OR PERTAIN TO DATA INTEGRITY.  Full Article

India's Indoco Remedies Gets 3 Critical Observations From UK-MHRA For Goa Facility
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Indoco Remedies Ltd ::UNITED KINGDOM - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (UK-MHRA) INSPECTED CO'S GOA DRUG MANUFACTURING FACILITY.INSPECTION TOOK PLACE BETWEEN MARCH 14 TO MARCH 16.UK-MHRA ISSUED OBSERVATIONS, WHICH INCLUDE 3 CRITICAL AND 4 MAJOR.  Full Article

India's Indoco Remedies Sept-qtr profit down nearly 11 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Indoco Remedies Ltd :Sept quarter profit 197.6 million rupees versus profit of 221.3 million rupees last year.Sept quarter revenue from operations 2.80 billion rupees versus 2.76 billion rupees last year.  Full Article

No consensus analysis data available.